So much of this commentary has genesis in emotion; not fact
Anchoring opinions in hindsight is a simple affair.
I know and have worked under both Craigs. The former particularly a smarter more humble man you will not meet
Did your offer go unacknowleged gdennis? 99 chances in 100 it did.
What you are suggesting re declining claims breaks so many Corps Law (and other) regs it decries belief.
Further, which insurance unit do you propose they sell? At what price? To who?
There's no question the AXA transaction multiple was too high. And the insurance unit will continue to underperform. But your recommendations are overly simplistic. It is an industry wide issue at the moment.
The better long term solution, in my view, is finding more sustainable commission pricing structures for distribution partners. Doesn't take a genius to work out 7 years break even on average 4 year policy life is bad business. This is the real crux of the issue but nobody wants to move firsy.
BTW - who offers the highest commissions in the industry?
It should come as no surprise!
- Forums
- ASX - By Stock
- AMP
- hot stock!
hot stock!, page-26
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AMP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
-0.020(1.30%) |
Mkt cap ! $3.835B |
Open | High | Low | Value | Volume |
$1.54 | $1.54 | $1.51 | $7.903M | 5.216M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 41331 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 589250 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 41331 | 1.510 |
4 | 89561 | 1.505 |
20 | 159002 | 1.500 |
1 | 40628 | 1.495 |
2 | 19891 | 1.490 |
Price($) | Vol. | No. |
---|---|---|
1.515 | 589250 | 9 |
1.520 | 87007 | 3 |
1.525 | 65606 | 4 |
1.530 | 41628 | 2 |
1.535 | 28000 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AMP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online